Envafolimab is under clinical development by Alphamab Oncology and currently in Phase I for Gastrointestinal Tract Cancer.
Lucicebtide is under clinical development by Sapience Therapeutics and currently in Phase II for Gastrointestinal Tract Cancer.
In early 2024, the World Health Organization predicted that by 2050 there will be more than 35 million new cancer cases ...
Experts discuss whether having caffeine first thing in the morning without food is actually harmful to your health.
Coffee beans processed by partial digestion in animals are among the world's rarest. Here’s an exclusive look at the world’s ...
Chicken gizzards are a highly underrated cut of meat, so cooking them can seem like a mystery at first. Here's how you can ...
We’re being scrappy," team lead for Tulane's cancer research contract Dr. J. Quincy Brown said. “It’s a white whale. This ...
Recalls can be issued for a variety of reasons, from undeclared allergens to plastic and bacterial contamination.
After heavy meals, discomfort is common. Newsweek explores how festive feasts impact your body and shares tips from experts on easing the aftermath.
There’s one potential party guest that you definitely want to steer clear of this New Year’s Eve: norovirus. Recent data from ...
So far this year, there have been 16 outbreaks on cruise ships, from norovirus, salmonella, e. coli or other unidentified ...
The proposed framework was tested with experiments on the WCE Curated Colon Disease (WCECCD) dataset, which contains a total of 4 classes of images, including 3 different GI tract diseases and normal.